PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27626217-5 2016 A total of 48 patients (48/81, 59.3%) were found to have DNMT3A mutations upon achieving CR. Chromium 89-91 DNA methyltransferase 3 alpha Homo sapiens 57-63 26759106-8 2015 DNMT3A+/FLT3-ITD+ CN-AML patients(n=14)had higher ORR and CR rates than DNMT3A-/FLT3-ITD+CN- AML patients(n=15)(P= 0.040 and 0.042, respectively). Chromium 58-60 DNA methyltransferase 3 alpha Homo sapiens 0-6 26759106-13 2015 Compared to DNMT3A-/FLT3- ITD+ CN- AML patients, DNMT3A+/ FLT3-ITD+ CN-AML patients had higher ORR and CR rates. Chromium 103-105 DNA methyltransferase 3 alpha Homo sapiens 49-55 24844834-6 2014 After treated by Cr (VI) for 24 h, the expression of mRNA and protein level among DNMT1, DNMT3a, DNMT3b and MBD2 decreased significantly in healthy 16HBE cells; and the expression of DNMT1 and DNMT3a decreased in PARG deficiency cells. Chromium 17-19 DNA methyltransferase 3 alpha Homo sapiens 89-95 24844834-6 2014 After treated by Cr (VI) for 24 h, the expression of mRNA and protein level among DNMT1, DNMT3a, DNMT3b and MBD2 decreased significantly in healthy 16HBE cells; and the expression of DNMT1 and DNMT3a decreased in PARG deficiency cells. Chromium 17-19 DNA methyltransferase 3 alpha Homo sapiens 193-199 21967546-8 2012 OS was not affected by DNMT3A mutation (P = 0.251), but OS of patients who reached CR was longer in DNMT3A negative cases (P = 0.025). Chromium 83-85 DNA methyltransferase 3 alpha Homo sapiens 100-106 21670448-7 2011 In cytogenetically normal (CN) AML, 27.2% harbored DNMT3A mutations that independently predicted shorter OS (HR = 2.46; 95% CI, 1.58 to 3.83; P < .001) and lower CR rate (OR, 0.42; 95% CI, 0.21 to 0.84; P = .015), but not RFS (P = .32). Chromium 165-167 DNA methyltransferase 3 alpha Homo sapiens 51-57 21670448-8 2011 Within patients with CN-AML, DNMT3A mutations had an unfavorable effect on OS, RFS, and CR rate in NPM1/FLT3-ITD high-risk but not in low-risk patients. Chromium 88-90 DNA methyltransferase 3 alpha Homo sapiens 29-35